Platelet-derived exosomes induce cell proliferation and wound healing in human endometrial cells
Abstract
Aim: To investigate the regenerative effects of a platelet-derived purified exosome product (PEP) on human endometrial cells. Materials & methods: Endometrial adenocarcinoma cells (HEC-1A), endometrial stromal cells (T HESC) and menstrual blood-derived stem cells (MenSC) were assessed for exosome absorption and subsequent changes in cell proliferation and wound healing properties over 48 h. Results: Cell proliferation increased in PEP treated T HESC (p < 0.0001) and MenSC (p < 0.001) after 6 h and in HEC-1A (p < 0.01) after 12 h. PEP improved wound healing after 6 h in HEC-1A (p < 0.01) and MenSC (p < 0.0001) and in T HESC between 24 and 36 h (p < 0.05). Conclusion: PEP was absorbed by three different endometrial cell types. PEP treatment increased cell proliferation and wound healing capacity.
Plain language summary
The uterus has a remarkable ability to heal itself. Every month the inside lining of the uterus grows in preparation for pregnancy and sheds if no pregnancy occurs. Unfortunately, this cycle of growth, shedding and repair can be injured and lead to menstrual changes, pain or even infertility. In this study, we looked how special cell messengers – called exosomes – could help uterine cells. Exosomes are special messengers that contain substances to help the body heal and regenerate injured cells and tissues. We obtained exosomes created from human transfusion-grade platelets. We studied the exosomes’ effects in three different cell types that all are important inside the uterine lining. Specifically, we studied the ability of the exosomes to help cells proliferate and migrate into a wound. In this study, exosomes were recognized by the human endometrial cells and were absorbed. Once they were inside the cells, they increased cell proliferation as well as the ability of the cells to heal a scratch wound. Furthermore, the more exosomes we presented to the cells, the more the cells were able to proliferate and move into a wound for healing. These findings lay the groundwork for future studies in animal models of uterine injury.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Regeneration and adult stem cells in the human female reproductive tract. Stem Cells Cloning 1, 23–29 (2008).
- 2. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol. Biomarkers Prev. 14(4), 799–804 (2005).
- 3. . Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann. NY Acad. Sci. 1221, 10–17 (2011). • The endometrium is thought to be a source of stem cells and may play a role in both physiologic and pathologic uterine biology such as in endometriosis.
- 4. . Intrauterine infusion of human platelet-rich plasma improves endometrial regeneration and pregnancy outcomes in a Murine Model of Asherman's Syndrome. Front. Physiol. 11, 105 (2020).
- 5. . Hysteroscopic Management of Asherman's Syndrome. J. Minim. Invasive Gynecol. 25(2), 218–228 (2018).
- 6. . Effects of uterus derived mesenchymal stem cells and their exosomes on Asherman's Syndrome. Acta Histochem. 122(1), 151465 (2020). • Mesenchymal stem cells and their exosomes restored the proliferative and vascularization potential (with a decrease in fibrosis) of the endometrium in a murine model of intrauterine adhesions.
- 7. . Exosomes for repair, regeneration and rejuvenation. Expert Opin. Biol. Ther. 16(4), 489–506 (2016).
- 8. . Exosomal therapy-a new frontier in regenerative medicine. Stem Cell Investig. 8, 7 (2021). • Exosomes are a natural target for delivering therapies, but there is a need for further study to make these therapies more accurate and cheaper.
- 9. . Tetraspanins in extracellular vesicle formation and function. Front. Immunol. 5, 442 (2014).
- 10. Exosomes derived from endometriotic stromal cells have enhanced angiogenic effects in vitro. Cell Tissue Res. 365(1), 187–196 (2016).
- 11. Characterization of a purified exosome product and its effects on canine flexor tenocyte biology. J. Orthop. Res. 38(8), 1845–1855 (2020).
- 12. Effects of purified exosome product on rotator cuff tendon-bone healing in vitro and in vivo. Biomaterials 276, 121019 (2021).
- 13. Administration of Purified Exosome Product in a Rat Sciatic Serve Reverse Autograft Model. Plast. Reconstr. Surg. 148(2), 200e–211e (2021).
- 14. TGF-beta loaded exosome enhances ischemic wound healing in vitro and in vivo. Theranostics 11(13), 6616–6631 (2021).
- 15. Impact of repeat dosing and mesh exposure chronicity on exosome-induced vaginal tissue regeneration in a Porcine Mesh Exposure Model. Female Pelvic Med. Reconstr. Surg. 27(3), 195–201 (2021). •• Treatment with platelet-derived exosomes resulted in increased epithelial proliferation with vascularization in a porcine model of mesh erosion.
- 16. . Regenerative medicine approach to augment surgical repair of anal sphincter injuries: injection of purified exosome product may improve anorectal manometry parameters and sphincter integrity. Am. J. Obstet. Gynecol. 222(3), S777–S778 (2020).
- 17. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman's syndrome. Hum. Reprod. 31(12), 2723–2729 (2016).
- 18. . NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9(7), 671–675 (2012).
- 19. . Dynamics of exosome internalization and trafficking. J. Cell. Physiol. 228(7), 1487–1495 (2013).
- 20. Clinical efficacy and safety of stem cell-based therapy in treating Asherman Syndrome: a system review and meta-analysis. Stem Cells Int. 2020, 8820538 (2020).
- 21. . Platelet-derived extracellular vesicles: an emerging therapeutic approach. Int. J. Biol. Sci. 13(7), 828–834 (2017).
- 22. . Regenerating endometrium from stem/progenitor cells: is it abnormal in endometriosis, Asherman's syndrome and infertility? Curr. Opin. Obstet. Gynecol. 25(3), 193–200 (2013). • Endometrial stem cells hold great promise as new treatments for a dysfunctional or scarred endometrium.
- 23. . Stem cell-based therapy for Asherman Syndrome: promises and challenges. Cell Transplant. 30, 9636897211020734 (2021).
- 24. . Effect of autologous platelet-rich plasma treatment on refractory thin endometrium during the frozen embryo transfer cycle: a pilot study. Front. Endocrinol. (Lausanne) 10, 61 (2019).
- 25. Endothelial cells in the decidual bed are potential therapeutic targets for preterm birth prevention. Cell Rep. 27(6), 1755–1768 e1754 (2019).
- 26. . Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist. Reprod. 21(1), 54–56 (2017).
- 27. . Platelet-rich plasma-derived extracellular vesicles: a superior alternative in regenerative medicine? Cell Prolif. 54(12), e13123 (2021).
- 28. . Exosomes: novel effectors of human platelet lysate activity. Eur. Cell Mater. 28, 137–151 (2014).
- 29. Rion, LLC. PEP exosome technology (2022). https://riontx.com/technology/
- 30. . Platelet-rich plasma: where are we now and where are we going? Sports Health 2(3), 203–210 (2010).
- 31. . Basic fibroblast growth factor controls the expression and molecular structure of heparan sulfate in corneal endothelial cells. Eur. J. Biochem. 234(2), 479–484 (1995).
- 32. . Living materials for regenerative medicine. Eng. Reg. 2, 96–104 (2021).
